FDA.reportPublic FDA data

LYNOZYFIC 200 MG in 10 ML Injection

RxCUI
2719490
RxNorm name
LYNOZYFIC 200 MG in 10 ML Injection
Display name
LYNOZYFIC 200 MG in 10 ML Injection
Full name
LYNOZYFIC 200 MG in 10 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761400Lynozyficlinvoseltamab-gcpt351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
e9fd0739-1b3f-4b8b-824a-1f0a902384d3LYNOZYFIC 200 MG in 10 ML InjectionPSN6These highlights do not include all the information needed to use LYNOZYFIC safely and effectively. See full prescribing information for LYNOZYFIC. LYNOZYFIC™ (linvoseltamab-gcpt) injection, for intravenous use Initial U.S. Approval: 202520250702
e9fd0739-1b3f-4b8b-824a-1f0a902384d310 ML Lynozyfic 20 MG/ML InjectionSY6These highlights do not include all the information needed to use LYNOZYFIC safely and effectively. See full prescribing information for LYNOZYFIC. LYNOZYFIC™ (linvoseltamab-gcpt) injection, for intravenous use Initial U.S. Approval: 202520250702
e9fd0739-1b3f-4b8b-824a-1f0a902384d310 ML linvoseltamab-gcpt 20 MG/ML Injection [Lynozyfic]SBD6These highlights do not include all the information needed to use LYNOZYFIC safely and effectively. See full prescribing information for LYNOZYFIC. LYNOZYFIC™ (linvoseltamab-gcpt) injection, for intravenous use Initial U.S. Approval: 202520250702
e9fd0739-1b3f-4b8b-824a-1f0a902384d3Lynozyfic 200 MG per 10 ML InjectionSY6These highlights do not include all the information needed to use LYNOZYFIC safely and effectively. See full prescribing information for LYNOZYFIC. LYNOZYFIC™ (linvoseltamab-gcpt) injection, for intravenous use Initial U.S. Approval: 202520250702